Arcus Capital Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-147
Closed -$3.48K – 318
2022
Q4
$3.48K Buy
+147
New +$3.96K ﹤0.01% 310

Other funds holding TDOC

Arcus Capital Partners's TDOC Position: Q1 2023 in Review

Arcus Capital Partners sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 147 shares — an estimated $3.48K sold.

Arcus Capital Partners first reported a position in TDOC in Q4 2022 and held it in 1 quarter. The position peaked at $3.48K in Q4 2022. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Arcus Capital Partners reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Arcus Capital Partners sold 147 Teladoc Health shares in Q1 2023, an estimated $3.48K.
  • Arcus Capital Partners first reported a position in Teladoc Health in Q4 2022 and held it in 1 quarter.
  • Arcus Capital Partners's Teladoc Health position peaked at $3.48K in Q4 2022.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Arcus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.